國立虎尾科技大學 |

Organotypic Models in Drug Development

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Organotypic Models in Drug Development/ edited by Monika Schäfer-Korting, Silvya Stuchi Maria-Engler, Robert Landsiedel.
other author:	Schäfer-Korting, Monika.
Description:	VIII, 323 p. 70 illus., 37 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Pharmacology. -
Online resource:	https://doi.org/10.1007/978-3-030-70063-8
ISBN:	9783030700638

Organotypic Models in Drug Development
Organotypic Models in Drug Development[electronic resource] /edited by Monika Schäfer-Korting, Silvya Stuchi Maria-Engler, Robert Landsiedel. - 1st ed. 2021. - VIII, 323 p. 70 illus., 37 illus. in color.online resource. - Handbook of Experimental Pharmacology,2651865-0325 ;. - Handbook of Experimental Pharmacology,224.

Inflammatory skin disease models in vitro and in animals – predictability for drug development -- Neural In Vitro Models for Studying Substances Acting on the Central Nervous System -- Quality of commercial tissues Standardised Reconstructed Skin Models in Toxicology and Pharmacology: State of the Art and Future Development -- Human-Derived In Vitro Models Used for Skin Toxicity Testing Under REACh -- Disease Models: Lung models for testing drugs against inflammation and infection -- In Vitro Models of the Blood-Brain Barrier -- How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug Development -- The CAM Assay as an Alternative In Vivo Model for Drug Testing -- Organotypic Models in Drug Development “Tumor Models and Cancer Systems Biology for the Investigation of Anticancer Drugs and Resistance Development -- Tissue Engineering for Musculoskeletal Regeneration and Disease Modeling -- Immunocompetent human intestinal models in preclinical drug development -- Engineered Heart Muscle Models in Phenotypic Drug Screens.

This book provides latest findings in organotypic models in drug development and provides the scientific resonance needed in an emerging field of research in disciplines, such as molecular medicine, physiology, and pathophysiology. Today the research on human-based test systems has gained major interest and funding in the EU and the US has increased over the last years. Moreover, so-called 3R (reduce, replace, refine animal experiments) centres have been established worldwide.

ISBN: 9783030700638

Standard No.: 10.1007/978-3-030-70063-8doiSubjects--Topical Terms:

583819
Pharmacology.

LC Class. No.: RM1-950

Dewey Class. No.: 615

Organotypic Models in Drug Development
LDR:03025nam a22004095i 4500 001 1045656
003 DE-He213
005 20210814154725.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030700638 $9 978-3-030-70063-8
024 7 $a 10.1007/978-3-030-70063-8 $2 doi
035 $a 978-3-030-70063-8
050 4 $a RM1-950
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615 $2 23
245 1 0 $a Organotypic Models in Drug Development $h [electronic resource] / $c edited by Monika Schäfer-Korting, Silvya Stuchi Maria-Engler, Robert Landsiedel.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a VIII, 323 p. 70 illus., 37 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Handbook of Experimental Pharmacology, $x 1865-0325 ; $v 265
505 0 $a Inflammatory skin disease models in vitro and in animals – predictability for drug development -- Neural In Vitro Models for Studying Substances Acting on the Central Nervous System -- Quality of commercial tissues Standardised Reconstructed Skin Models in Toxicology and Pharmacology: State of the Art and Future Development -- Human-Derived In Vitro Models Used for Skin Toxicity Testing Under REACh -- Disease Models: Lung models for testing drugs against inflammation and infection -- In Vitro Models of the Blood-Brain Barrier -- How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug Development -- The CAM Assay as an Alternative In Vivo Model for Drug Testing -- Organotypic Models in Drug Development “Tumor Models and Cancer Systems Biology for the Investigation of Anticancer Drugs and Resistance Development -- Tissue Engineering for Musculoskeletal Regeneration and Disease Modeling -- Immunocompetent human intestinal models in preclinical drug development -- Engineered Heart Muscle Models in Phenotypic Drug Screens.
520 $a This book provides latest findings in organotypic models in drug development and provides the scientific resonance needed in an emerging field of research in disciplines, such as molecular medicine, physiology, and pathophysiology. Today the research on human-based test systems has gained major interest and funding in the EU and the US has increased over the last years. Moreover, so-called 3R (reduce, replace, refine animal experiments) centres have been established worldwide.
650 0 $a Pharmacology. $3 583819
650 0 $a Gene therapy. $3 582271
650 0 $a Pathology. $3 668553
650 1 4 $a Pharmacology/Toxicology. $3 593882
650 2 4 $a Gene Therapy. $3 580629
700 1 $a Schäfer-Korting, Monika. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1349063
700 1 $a Stuchi Maria-Engler, Silvya. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1349064
700 1 $a Landsiedel, Robert. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1303782
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030700621
776 0 8 $i Printed edition: $z 9783030700645
776 0 8 $i Printed edition: $z 9783030700652
830 0 $a Handbook of Experimental Pharmacology, $x 0171-2004 ; $v 224 $3 1254015
856 4 0 $u https://doi.org/10.1007/978-3-030-70063-8
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)